These T‐DM1 surface‐engineered NK (SE‐NK/T‐DM1) cells, the product generated using our approach, recognized and destroyed human epidermal growth factor receptor 2 (HER2)‐positive cancer cells through the combined activity of T‐DM1 and NK cells. The gene discussed is ERBB2; the disease is cancer.